Clinical Trial Update: Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated the efficacy and safety of alirocumab (SAR236553/REGN727) in Japanese patients with primary hypercholesterolemia on stable atorvast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2015-09-24